Helping you make wiser investment decisions

BeiGene, Hutchmed, Zai Lab tagged for potential US delisting under SEC audit rules, with more Chinese biotechs likely to face scrutiny

March 11, 2022 aliu



BeiGene, Hutchmed, Zai Lab tagged for potential US delisting under SEC audit rules, with more Chinese biotechs likely to face scrutiny
aliu
Fri, 03/11/2022 – 10:01



Source link